Literature DB >> 2942687

Acromegalic arthropathy: a reversible rheumatic disease.

S Lacks, R P Jacobs.   

Abstract

Acromegalic arthropathy may be the initial manifestation of growth hormone over-production. The presence of an underlying endocrinopathy may go unrecognized for a long period of time because of the predominance of articular signs and symptoms. We describe 2 cases of acromegaly presenting with rheumatologic manifestations, the first resembling seronegative rheumatoid arthritis, the second, post traumatic low back syndrome. Unlike previous reports, both our cases showed resolution of musculoskeletal symptoms after pituitary surgery.

Entities:  

Mesh:

Year:  1986        PMID: 2942687

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  6 in total

1.  Acromegalic arthropathy.

Authors:  A L Barkan
Journal:  Pituitary       Date:  2001-09       Impact factor: 4.107

2.  Rheumatoid arthritis masquerading as acromegaly recurrence: report of two cases.

Authors:  Yusuf Aydın; Hülya Coşkun; Seher Kır; Selma Yazici; Özlem Kudaş; Adem Güngör
Journal:  Rheumatol Int       Date:  2010-04-06       Impact factor: 2.631

Review 3.  Rheumatic manifestations of pituitary tumors.

Authors:  S Stavrou; D L Kleinberg
Journal:  Curr Rheumatol Rep       Date:  2001-10       Impact factor: 4.592

4.  A challenging case of rheumatoid arthritis in an acromegalic patient.

Authors:  Levent Ozçakar; Ayşen Akinci; Serpil Bal
Journal:  Rheumatol Int       Date:  2003-02-05       Impact factor: 2.631

5.  Is every joint symptom related to acromegaly?

Authors:  Gonca Örük; Figen Tarhan; Mehmet Argın; Mustafa Özmen
Journal:  Endocrine       Date:  2012-08-21       Impact factor: 3.633

6.  Ultrasonographic measurement of femoral cartilage thickness in acromegalic patients.

Authors:  Murat Karkucak; İbrahim Batmaz; Nadim Civan; Fatih Kilinc; Erhan Capkin; Mustafa Akif Sariyildiz; Melek Aslan Garipoğlu; Mustafa Avni Onder; Levent Ozcakar
Journal:  Clin Rheumatol       Date:  2014-02-27       Impact factor: 2.980

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.